Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank80
3Y CAGR-0.8%
5Y CAGR+35.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-0.8%/yr
Annual compound
5Y CAGR
+35.6%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
4.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $20.27M | +17.8% |
| 2024 | $17.20M | +23.7% |
| 2023 | $13.91M | -33.0% |
| 2022 | $20.78M | +61.5% |
| 2021 | $12.86M | +190.6% |
| 2020 | $4.43M | - |